Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion type Assertion NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_head.
- NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion wasGeneratedBy ECO_0000203 NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_provenance.
- NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion wasDerivedFrom befree-20150227 NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_provenance.
- NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion SIO_000772 22805863 NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_provenance.
- NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion evidence source_evidence_literature NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_provenance.
- NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_assertion description "[High expression of IRF-1 was associated with good outcome (p<.001 for OS/TTR), while high expression of IRF-2 was relevant to increased recurrence probability (p=.049) in HCC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514572.RAtlZbyuSby_QxbFOPUogfNeLoGlJo-LqMSgDmHBZF1VI130_provenance.